During the past decade, First Coast Cardiovascular Institute conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 20 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Coast Cardiovascular Institute" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Boston Scientific Corporation" with 5 trials sponsored, "Saint Luke's Health System" with 3 trials sponsored, "C. R. Bard" with 2 trials sponsored and "Cook Group Incorporated" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First Coast Cardiovascular Institute" #1 collaborator was "Syntactx" with 2 trials as a collaborator, "Advanced Catheter Therapies, Inc." with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator and "ClinLogix. LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "First Coast Cardiovascular Institute" are "Peripheral Arterial Disease" (10 trials), "Heart Failure" (6 trials), "Peripheral Vascular Disease" (4 trials), "Carotid Stenosis" (2 trials) and "Critical Limb Ischemia" (2 trials). Many other conditions were trialed in "First Coast Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "First Coast Cardiovascular Institute" are "Device" (31 trials), "Other" (7 trials), "Drug" (5 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin matching placebo" (2 trials), "Esprit BTK Device" (2 trials), "Placebo" (2 trials), "Standard of Care, Diabetic Foot Ulcers" (2 trials) and "AMNIOEXCEL" (1 trials). Other intervention names were less common.

The vast majority of trials in "First Coast Cardiovascular Institute" are 46 trials for "All" genders.

Currently, there are NaN active trials in "First Coast Cardiovascular Institute". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in First Coast Cardiovascular Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in First Coast Cardiovascular Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 32 trials that are defined as “Not Applicable".